Invention Application
- Patent Title: CELL REPROGRAMMING THERAPY
-
Application No.: PCT/US2019/013367Application Date: 2019-01-11
-
Publication No.: WO2019140315A2Publication Date: 2019-07-18
- Inventor: PAREKKADAN, Biju , LI, Matthew
- Applicant: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY , THE GENERAL HOSPITAL CORPORATION
- Applicant Address: 83 Somerset Street New Brunswick, NJ 08901 US
- Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY,THE GENERAL HOSPITAL CORPORATION
- Current Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY,THE GENERAL HOSPITAL CORPORATION
- Current Assignee Address: 83 Somerset Street New Brunswick, NJ 08901 US
- Agency: BALICKY, Eric M. et al.
- Priority: US62/616,930 20180112
- Main IPC: C12N5/07
- IPC: C12N5/07
Abstract:
Systems and methods for the dynamic co-culturing of two cell populations are provided. The system includes a barrier configured to physically separate a stimulator cell population from a responder cell population disposed within a container. The barrier is permeable to the secreted factors of at least one of the cell populations. The responder cell population can thereby be altered by exposure to the secreted factors to produce a population of reprogrammed cells that includes biomolecules (e.g., nucleic acids) originating from the stimulator cell population and/or that exhibits one or more additional or modified functional activities than a parental population of the reprogrammed cells.
Public/Granted literature
- WO2019140315A3 CELL REPROGRAMMING THERAPY Public/Granted day:2019-07-18
Information query